These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37354488)

  • 1. An integrated bioinformatic investigation of focal adhesion-related genes in glioma followed by preliminary validation of COL1A2 in tumorigenesis.
    Yao G; Deng L; Long X; Zhou Y; Zhou X
    Aging (Albany NY); 2023 Jun; 15(13):6225-6254. PubMed ID: 37354488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetraspanins predict the prognosis and characterize the tumor immune microenvironment of glioblastoma.
    Li YC; Wu Y; Chen G; Zhu LZ; Luo X; Nie QQ; Zhang L; Zuo CJ
    Sci Rep; 2023 Aug; 13(1):13317. PubMed ID: 37587203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
    Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A
    Front Immunol; 2022; 13():961933. PubMed ID: 35990696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of oxidative stress-related lncRNA signatures in glioma reveals the discrepancy of prognostic and immune infiltration.
    Shi Z; Wu Y; Zhuo Q; Zuo Y; Lin J; Shi H; Zhou H; Xu Z
    Sci Rep; 2023 May; 13(1):7731. PubMed ID: 37173373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined bulk RNA-seq and single-cell RNA-seq identifies a necroptosis-related prognostic signature associated with inhibitory immune microenvironment in glioma.
    Wan S; Moure UAE; Liu R; Liu C; Wang K; Deng L; Liang P; Cui H
    Front Immunol; 2022; 13():1013094. PubMed ID: 36466844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a robust scoring system based on metabolic genes followed by in-depth validation of ATP1A3 in glioma.
    Ji Q; Tu Z; Liu J; Huang K; Zhu X; Li J
    Life Sci; 2023 Feb; 315():121377. PubMed ID: 36627101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of COL6A2 in malignant progression and temozolomide resistance of glioma.
    Hong X; Zhang J; Zou J; Ouyang J; Xiao B; Wang P; Peng X
    Cell Signal; 2023 Feb; 102():110560. PubMed ID: 36521657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis.
    Zhao B; Wang Y; Wang Y; Dai C; Wang Y; Ma W
    Front Immunol; 2021; 12():557994. PubMed ID: 34220791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pyroptosis-related signature predicts prognosis and indicates immune microenvironment infiltration in glioma.
    Chen J; Chen S; Li B; Zhou S; Lin H
    Cancer Med; 2023 Feb; 12(4):5071-5087. PubMed ID: 36161280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma.
    Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q
    Front Immunol; 2022; 13():1011757. PubMed ID: 36325335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of m
    Zhao K; Li W; Yang Y; Hu X; Dai Y; Huang M; Luo J; Zhang K; Zhao N
    Front Immunol; 2022; 13():955848. PubMed ID: 36203569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omics approaches establishing histone modification based prognostic model in glioma patients and further verification of the carcinogenesis mechanism.
    Wang Y; Ji L; Ji C; Wang F
    Funct Integr Genomics; 2023 Sep; 23(4):307. PubMed ID: 37730879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis related genes based prognostic model of glioma patients developed by multi-omics approach.
    Liu Z; Fan H; Liu X; Liu C
    Discov Oncol; 2024 Jul; 15(1):296. PubMed ID: 39033204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of INSRR as an immune-related gene in the tumor microenvironment of glioblastoma by integrated bioinformatics analysis.
    Zhang H; Bao M; Liao D; Zhang Z; Tian Z; Yang E; Luo P; Jiang X
    Med Oncol; 2023 Apr; 40(6):161. PubMed ID: 37099121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Diverse Cell Death Patterns Related Gene Signature and Prognosis, Drug Sensitivity, and Immune Microenvironment in Glioblastoma.
    Li J; Song Z; Chen Z; Gu J; Cai Y; Zhang L; Wang Z
    J Mol Neurosci; 2024 Jan; 74(1):10. PubMed ID: 38214842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of the prognostic and immunological signature of eight Tripartitemotif (TRIM) family molecules in human gliomas.
    Lu J; Liang K; Zou R; Peng Y; Wang H; Huang R; Zeng Z; Feng Z; Fan Y; Zhang S; Ji Y; Pang X; Wang Y; Zhang H; Wang Z
    Aging (Albany NY); 2023 Jun; 15(12):5798-5825. PubMed ID: 37367937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
    Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
    Front Immunol; 2022; 13():899710. PubMed ID: 35677036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell senescence-associated genes predict the malignant characteristics of glioblastoma.
    Tan C; Wei Y; Ding X; Han C; Sun Z; Wang C
    Cancer Cell Int; 2022 Dec; 22(1):411. PubMed ID: 36527013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.